Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Oncoimmunology|September 14, 2016
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM WorkshopRoch Houot, Philippe Gaulard, Robert Schreiber, et al.Blood Advances|July 17, 2020
Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE studyMarie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, et al.Blood|April 18, 2014
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemiaKheira Beldjord, Sylvie Chevret, Vahid Asnafi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2016
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 CasesSydney Dubois, Pierre-Julien Viailly, Elodie Bohers, et al.Blood|October 25, 2017
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphomaThierry Lamy, Gandhi Damaj, Pierre Soubeyran, et al.Current Biology : CB|January 29, 2022
Natural and human-driven selection of a single non-coding body size variant in ancient and modern canidsJocelyn Plassais, Bridgett M vonHoldt, Heidi G Parker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2016
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA StudySydney Dubois, Pierre-Julien Viailly, Sylvain Mareschal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With ImmunochemotherapyHervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.Molecular Cancer Therapeutics|May 11, 2018
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and LeukemiaVanessa Buatois, Zoë Johnson, Susana Salgado-Pires, et al.Blood Advances|March 3, 2025
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphomaVincent Camus, Thierry Molina, Fabienne Desmots, et al.Pageof 10